BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, June 21, 2026
Home » Authors » Omar Ford

Articles by Omar Ford

Healthcare spending fairly low, could pick up as economy recovers

July 16, 2013
By Omar Ford

Panel discusses impact of ACA on both healthcare delivery, cost

July 15, 2013
By Omar Ford
Potential impacts of the Affordable Care Act (ACA), specifically regarding healthcare delivery and costs, were the topics of discussion for RBC Capital Markets, as the firm held a conference call late last week.
Read More

MPM secures $8.5M to develop tech to treat mitral valve disease

July 11, 2013
By Omar Ford

Intuitive sees less than stellar 2Q13 sales of da Vinci system

July 10, 2013
By Omar Ford
Intuitive Surgical (Sunnyvale, California) saw a drop in its shares Tuesday, after the company issued a gloomy second-quarter sales warning due to lighter sales of the da Vinci medical system. The shares dropped 15% to an 18 month low for the company.
Read More

Penumbra launches 5MAX ACE blood clot removal application

July 9, 2013
By Omar Ford
Penumbra (Alameda, California) reported the launch and wide availability of the 5MAX ACE, a next generation clot extraction device that uses aspiration alone to engage and remove blood clots causing an acute ischemic stroke.
Read More

Researchers develop telescope-like contact lens for AMD patients

July 8, 2013
By Omar Ford

NanoString's Prosigna supported by publication of validation study

July 3, 2013
By Omar Ford

Myriad patent ruling has positives, negatives but bad for investors

July 2, 2013
By Omar Ford

Deals roundup: Bard to sell Electrophysiology unit to Boston Sci for $275M

July 1, 2013
By Omar Ford

Multicenter study to evaluate HeartLight for persistent AF

July 1, 2013
By Omar Ford
CardioFocus (Marlborough, Massachusetts), a developer of the HeartLight Endoscopic Ablation System for the treatment of atrial fibrillation (AF), said that its HeartLight technology is the focus of a multicenter European clinical study for the treatment of drug-refractory persistent AF.
Read More
Previous 1 2 … 106 107 108 109 110 111 112 113 114 … 227 228 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 18, 2026.
  • Wireframe of feet and scale

    GLP-1s need technologies for long-term use

    BioWorld
    For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
  • UTRN gene involved in arthrogryposis, study finds

    BioWorld Science
    Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
  • Blue-gray dollar sign

    HMNC raises $50M series B to prep depression drugs for phase III

    BioWorld
    HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
  • Illustration of glucose in the blood stream

    CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research

    BioWorld Science
    Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing